Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the Challenges of Vaccine Hesitancy Broadly and Related to COVID-19 Vaccines.

Topics in antiviral medicine·2022
Same author

The Productivity Requirements of Implementing a Medical Scribe Program.

Annals of internal medicine·2020
Same author

Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association.

Progress in cardiovascular diseases·2020
Same author

Optimal Panel Size: Are We Asking the Right Question?

Annals of internal medicine·2020
Same author

Practical Ways to Address Physician Burnout and Improve Joy in Practice.

Family practice management·2019
Same author

ACR Appropriateness Criteria<sup>®</sup> Acute Hip Pain-Suspected Fracture.

Journal of the American College of Radiology : JACR·2019
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Medication adherence: WHO cares?

Marie T Brown1, Jennifer K Bussell

  • 1Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. mariebrown@drsbrownforbes.com

Mayo Clinic Proceedings
|March 11, 2011
PubMed
Summary
This summary is machine-generated.

Improving medication adherence for chronic illnesses is crucial. Multifactorial strategies are needed to address patient, physician, and healthcare system barriers to pharmacotherapy, especially in cardiovascular disease management.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Related Experiment Videos

Last Updated: Jun 3, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Area of Science:

  • Pharmacology and Health Services Research
  • Patient Adherence Studies

Background:

  • Chronic illness management relies heavily on pharmacotherapy.
  • Medication non-adherence affects approximately 50% of patients, limiting treatment efficacy.
  • Barriers to adherence are complex, involving patients, physicians, and healthcare systems.

Purpose of the Study:

  • To review general aspects of medication adherence.
  • To examine adherence in cardiovascular disease patients.
  • To identify strategies for improving medication adherence.

Main Methods:

  • MEDLINE literature search (1990-2010) using keywords: cardiovascular disease, health literacy, medication adherence, pharmacotherapy.
  • Screening of 405 retrieved articles, yielding 127 for review.
  • Inclusion of additional references from cited articles.

Main Results:

  • Identified numerous patient-related factors (e.g., health literacy, decision-making involvement).
  • Highlighted physician-related barriers (e.g., complex regimens, communication issues).
  • Noted healthcare system challenges (e.g., visit time, access to care).

Conclusions:

  • Improving medication adherence requires multifactorial solutions.
  • Addressing diverse barriers is essential for effective pharmacotherapy.
  • Strategies and resources exist to enhance patient adherence in chronic disease care.